NVO Description — Novo-Nordisk AS

Novo-Nordisk is a healthcare company. Co. is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products and has two segments: diabetes and obesity care and biopharm. The diabetes and obesity care segment covers insulin, GLP-1 and related delivery systems, oral antidiabetic products, obesity and other diseases. The biopharm segment covers the therapy areas of haemophilia, growth disorders and hormone replacement therapy. Co.'s products include NovoLog®/ NovoRapid®, NovoLog Mix®/ NovoMix®, Levemir®, Victoza®, Tresiba®, Ryzodeg®, Xultophy®, Fiasp®, Ozempic®, Saxenda®, Rybelsus® , NovoSeven®, NovoEight®, Rebinyn®/ Refixia®, Norditropin®, Esperoct® and devices.

Company Name: 
Novo-Nordisk AS
Drugs & Pharmaceuticals
Number of ETFs Holding NVO: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   NVO Weight   NVO Amount 
 FVD   0.48%   $58,185,375         
 PPH   5.95%   $19,480,003         
 FDIV   1.07%   $746,823         
Quotes delayed 20 minutes

Buy (2.60 out of 4)
3rd percentile
(ranked lower than approx. 97% of all stocks covered)

Analysts Forecast:
NVO Price Target

Based on data provided by Zacks Investment Research via

ETFs Holding NVO | Novo-Nordisk AS | ETF Channel |

Copyright © 2010 - 2021, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.